Literature DB >> 17224736

The Asp40 mu-opioid receptor allele does not predict naltrexone treatment efficacy in heavy drinkers.

Jennifer M Mitchell, Howard L Fields, Raymond L White, Thomas M Meadoff, Geoff Joslyn, Michael C Rowbotham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17224736     DOI： 10.1097/JCP.0b013e31802e68b0

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  12 in total

1.  Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation.

Authors:  Stephanie S O'Malley; Suchitra Krishnan-Sarin; Sherry A McKee; Robert F Leeman; Ned L Cooney; Boris Meandzija; Ran Wu; Robert W Makuch
Journal:  Int J Neuropsychopharmacol       Date:  2008-09-17       Impact factor: 5.176

2.  A pilot study of naltrexone and BASICS for heavy drinking young adults.

Authors:  Robert F Leeman; Rebekka S Palmer; William R Corbin; Denise M Romano; Boris Meandzija; Stephanie S O'Malley
Journal:  Addict Behav       Date:  2008-04-13       Impact factor: 3.913

Review 3.  Personalized treatment of alcohol dependence.

Authors:  Henry R Kranzler; James R McKay
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

Review 4.  Pharmacogenetics of alcohol and alcohol dependence treatment.

Authors:  Henry R Kranzler; Howard J Edenberg
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

5.  A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys.

Authors:  Eric J Vallender; Daniela Rüedi-Bettschen; Gregory M Miller; Donna M Platt
Journal:  Drug Alcohol Depend       Date:  2010-02-13       Impact factor: 4.492

6.  Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment.

Authors:  Henry R Kranzler; Stephen Armeli; Jonathan Covault; Howard Tennen
Journal:  Addict Biol       Date:  2012-07-11       Impact factor: 4.280

Review 7.  Genetics of alcohol dependence.

Authors:  Joel Gelernter; Henry R Kranzler
Journal:  Hum Genet       Date:  2009-06-17       Impact factor: 4.132

8.  Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers.

Authors:  Albert J Arias; Stephen Armeli; Joel Gelernter; Jonathan Covault; Antero Kallio; Sakari Karhuvaara; Tiina Koivisto; Rauno Mäkelä; Henry R Kranzler
Journal:  Alcohol Clin Exp Res       Date:  2008-07       Impact factor: 3.455

Review 9.  Pharmacogenetically driven treatments for alcoholism: are we there yet?

Authors:  Albert J Arias; R Andrew Sewell
Journal:  CNS Drugs       Date:  2012-06-01       Impact factor: 5.749

10.  Substance use disorders assessed using the Kreek-McHugh-Schluger-Kellogg (KMSK) scale in an urban low-income and predominantly African American sample of primary care patients.

Authors:  Yi-lang Tang; Lamya Khoury; Bekh Bradley; Charles F Gillespie; Kerry J Ressler; Joseph F Cubells
Journal:  Am J Addict       Date:  2011-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.